Innovation Pharmaceuticals Inc.

OTCPK:IPIX Stock Report

Market Cap: US$793.9k

Innovation Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Leo Ehrlich

Chief executive officer

US$515.9k

Total compensation

CEO salary percentage90.3%
CEO tenure16.9yrs
CEO ownership1.3%
Management average tenureno data
Board average tenure8.2yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Leo Ehrlich's remuneration changed compared to Innovation Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$3m

Jun 30 2023US$516kUS$466k

-US$3m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022n/an/a

-US$5m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022US$906kUS$466k

-US$7m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021n/an/a

-US$10m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021US$516kUS$466k

-US$14m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020n/an/a

-US$10m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020US$545kUS$466k

-US$7m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019n/an/a

-US$7m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019US$466kUS$466k

-US$9m

Mar 31 2019n/an/a

-US$12m

Dec 31 2018n/an/a

-US$13m

Sep 30 2018n/an/a

-US$14m

Jun 30 2018US$466kUS$466k

-US$16m

Mar 31 2018n/an/a

-US$17m

Dec 31 2017n/an/a

-US$18m

Sep 30 2017n/an/a

-US$17m

Jun 30 2017US$466kUS$466k

-US$16m

Compensation vs Market: Leo's total compensation ($USD515.85K) is about average for companies of similar size in the US market ($USD661.60K).

Compensation vs Earnings: Leo's compensation has been consistent with company performance over the past year.

CEO

Leo Ehrlich (65 yo)

16.9yrs

Tenure

US$515,850

Compensation

Mr. Leo Ehrlich, CPA serves as Chairman at Innovation Pharmaceuticals Inc. He has been the Chief Executive Officer and Chief Financial Officer of Innovation Pharmaceuticals Inc. (previously known as Cellce...

Board Members

NamePositionTenureCompensationOwnership
Leo Ehrlich
Chairman16.5yrsUS$515.85k1.34%
$ 10.6k
William DeGrado
Scientific Advisor of Drug Discovery & Clinical Development3.8yrsno datano data
Stephen T. Sonis
Scientific Advisor of Oral Mucositis & Member of the Advisory Board8.2yrsno datano data
Francis Farraye
Scientific Advisor of Gastroenterology & Member of the Advisory Boardno datano datano data
Paul Ginsburg
Scientific Advisor of Intellectual Property13.1yrsno datano data
Gustavo Goldman
Scientific Advisor of Mycology & Fungal Diseases and Member of the Advisory Board1.1yrsno datano data

8.2yrs

Average Tenure

Experienced Board: IPIX's board of directors are considered experienced (8.2 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.